| Income Statement | 2025-09-28 | 2025-06-29 | 2025-03-30 | 2024-09-29 |
|---|---|---|---|---|
| Total revenues | 699,900 | 613,900 | 692,800 | 727,100 |
| Cost of sales, excluding amortization of intangibles | 364,300 | 339,000 | 349,500 | 374,800 |
| Selling, marketing and administrative | 186,900 | 178,000 | 187,000 | 186,400 |
| Integration related costs | - | - | 16,100 | 36,800 |
| Research and development | 41,500 | 45,700 | 53,200 | 55,900 |
| Amortization of intangible assets | 47,700 | 47,900 | 48,000 | 51,900 |
| Restructuring, integration and other charges | 39,600 | 178,900 | - | - |
| Goodwill impairment charge | 700,700 | 0 | - | - |
| Asset impairment charge | 9,700 | 0 | - | - |
| Other operating expenses | 14,300 | 5,100 | 6,400 | 6,300 |
| Operating (loss) income | -704,800 | -180,700 | 32,600 | 15,000 |
| Interest expense, net | 46,100 | 40,500 | 40,000 | -42,900 |
| Loss on extinguishment of debt | -5,100 | - | - | - |
| Other expense, net | -900 | -8,400 | -1,400 | -900 |
| Loss before income taxes | -756,900 | -229,600 | -8,800 | -28,800 |
| (benefit from) provision for income taxes | -23,900 | 25,800 | 3,900 | -8,900 |
| Net loss | -733,000 | -255,400 | -12,700 | -19,900 |
| Basic loss per share | -10.78 | -3.77 | -0.19 | -0.3 |
| Diluted loss per share | -10.78 | -3.77 | -0.19 | -0.3 |
| Weighted-average shares outstanding - basic | 68,000,000 | 67,700,000 | 67,500,000 | 67,300,000 |
| Weighted-average shares outstanding - diluted | 68,000,000 | 67,700,000 | 67,500,000 | 67,300,000 |
QuidelOrtho Corp (QDEL)
QuidelOrtho Corp (QDEL)